Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.
$599
Posted in: Glucose Monitoring Mar 07 | 2019Dexcom Loses Appeals Court Bid For AgaMatrix LawsuitPurchase Blast$599
Posted in: Basal Insulin Mar 06 | 2019Thoughts on Biocon Form 483 Observations and Impact to Semglee US LaunchPurchase Blast$599
Posted in: Glucose Monitoring, Insulin Delivery, Other Mar 05 | 2019New Glooko Business Model; Glooko Mobile App to be Given Away for FreePurchase Blast$599
Posted in: Bolus Insulin, Insulin Delivery Mar 04 | 2019Thoughts on Lilly’s Humalog Authorized GenericPurchase Blast$599
Posted in: Bolus Insulin Mar 01 | 2019Fiasp Pediatric Indication Filed in US and EUPurchase Blast$599
Posted in: SGLT2i Mar 01 | 2019Sota/Dapa T1DM EU Regulatory Analysis; Sota Receives Positive CHMP OpinionPurchase Blast$599
Posted in: GLP-1RA + Basal Feb 28 | 2019Xultophy Label Update at Parity with SoliquaPurchase Blast$599
Posted in: Basal Insulin, GLP-1RA, GLP-1RA + Basal Feb 27 | 2019Soliqua Label Update More Competitive vs. Xultophy and BasaglarPurchase Blast$599
Posted in: Basal Insulin, Insulin Delivery Feb 26 | 2019Tandem and Mylan Q4 '18 Earnings UpdatesPurchase Blast$599
Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, Dual/triple agonist, GLP-1RA, GLP-1RA + Basal, Glucagon, Insulin Delivery, Other, SGLT2i Feb 26 | 2019Diabetes Takes a Backseat During Part II Drug Pricing HearingPurchase Blast$599
Posted in: Insulin Delivery Feb 25 | 2019Omnipod Horizon Receives Breakthrough Device Designation; Q4 '18 Earnings UpdatePurchase Blast$599
Posted in: Other, SGLT2i Feb 25 | 2019Farxiga eGFR Cutoff Lowered; Positive Brilinta T2DM DataPurchase Blast$599
Posted in: Basal Insulin, Bolus Insulin, Insulin Delivery, Other Feb 23 | 2019Thoughts on New Hygieia d-Nav Mobile App for Insulin Titration; New Data published in The LancetPurchase Blast$599
Posted in: Glucose Monitoring Feb 21 | 2019Dexcom Expands Customer Support; Q4 '18 Earnings UpdatePurchase BlastGet the Latest Analysis
Stay informed and aligned with frequent updates to keep a pulse on the industry.
If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.